An Independent Review
Home About Us Contact Us Index Search Consumer Topics Back Issues

Subject Index: Australian Prescriber Volumes 17 to current (1994-2008)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

To find a reference on this page either scroll or hold down the "Ctrl" key and press "f".

obesity
  • diabetes and antipsychotics 27(5) 118-9
    		•
  • management 29(2) 43-7; 22(1) 12-6
    		•
  • management in children 26(2) 30-2
    		•
  • orlistat - Xenical (New drug) 23(3) 64-7
    		•
  • sibutramine - Reductil (New drug) 25(1) 20-3
    		•
    obsessive compulsive disorder
  • antidepressants - clinical applications 22(5) 108-11
    		•
  • fluvoxamine - Luvox (New drug) 20(3) 77-9
    		•
  • in osteoarthritis 18(1) 2-4
    		•
  • letter 18(4) 84-6
    		•
    obstetrics
  • carbetocin - prevention of uterine atony after caesarian section - Duratocin (New drug) 30(4) 107-11
    		•
  • pethidine in labour pain 27(2) 34-5
    		•
    ocreotide
  • Sandostatin (New strength) 23(2) 45-6
    		•
    Ocufen
  • see flurbiprofen 17(1) 6-8
    		•
    Ocuflox
  • see ofloxacin 18(2) 35-8
    		•
    ocular toxoplasmosis
  • treatment 25(4) 88-90
    		•
  • letter 26(3) 51-2
    		•
    oculogyric crisis
  • oculogyric crisis 24(1) 19-20
    		•
    Odrik
  • see trandolapril 17(4) 87-90
    		•
    oesophagitis - see gastro-oesophageal reflux
    oestradiol
  • Aerodiol (New formulation) 26(5) 118-9
    		•
  • Climara 25 and 75 (New strengths) 24(2) 43-7
    		•
  • cyproterone combination - Climen 28 (New brand) 24(2) 43-7
    		•
  • Divina (New drug) 18(3) 58-9
    		•
  • editorial 23(5) 90-2
    		•
  • Estalis (New combination) 23(5) 110-1
    		•
  • Femtran 25 and 75 (New strength) 24(1) 20-3
    		•
  • Kliogest (New combination) 19(3) 81-3
    		•
  • Kliovance (New brand) 22(6) 147-51
    		•
  • new strength - Estracombi 19(2) 38-40
    		•
  • oestradiol valerate and cyproterone acetate - Climen (New combination) 19(3) 81-3
    		•
  • Sandrena (New formulation) 21(4) 108-11
    		•
    oestrogens
  • hormone replacement therapy (editorial) 23(5) 90-2
    		•
  • medroxyprogesterone combination - Premia (New strength) 24(6) 155-8
    		•
  • regimens 17(1) 13-6
    		•
  • medroxyprogesterone combination - Premia Low (New strength) 27(1) 21-3
    		•
    off-label prescribing
  • children (editorial) 26(6) 122-3
    		•
  • letters 28(1) 5-7; 27(2) 28-33
    		•
  • letter 27(4) 82-3
    		•
    ofloxacin
  • conjunctivitis - Ocuflox (New drug) 18(2) 35-8
    		•
    olanzapine
  • in bipolar disorders 30(3) 70-3
    		•
  • new antipsychotic drugs 22(4) 81-3
    		•
  • in pregnancy and breastfeeding 30(6) 162-3
    		•
  • schizophrenia - Zyprexa (New drug) 20(3) 77-9
    		•
  • Zyprexa (New formulation) 27(4) 101-5
    		•
  • Zyprexa Zydis (New formulation) 23(5) 110-1
    		•
    older persons - see aged
    olmesartan medoxomil
  • Olmetec - hypertension (New drug) 30(3) 79-82
    		•
    Olmetec
  • see olmesartan medoxomil 30(3) 79-82
    		•
    olopatadine
  • histamine H1 antagonist - allergic seasonal conjunctivitis - Patanol (New drug) 25(6) 147-51
    		•
    omalizumab
  • asthma - Xolair (New drug) 26(6) 146-51
    		•
    omeprazole
  • Acimax (new formulation) 23(1) 21-3
    		•
  • gastrointestinal haemorrhage (letter) 28(6) 136-9
    		•
  • and hyponatraemia 28(2) 48-9
    		•
  • and interstitial nephritis 30(3) 67
    		•
    Omniscan
  • see gadodiamide 17(2) 30-2
    		•
    onchocerciasis
  • ivermectin - Stromectol (New drug) 20(3) 77-9
    		•
    oncology - see cancer; antineoplastics
    Onco-Tain
  • see fluorouracil 22(6) 147-51
    		•
    ondansetron
  • Zofran (New formulations) 22(4) 95-8; 21(4) 108-11; 21(2) 49-55
    		•
    Onkotrone
  • see mitozantrone 24(4) 100-2
    		•
    Ontario
  • drug costs policies 25(6) 128-30
    		•
    onychomycosis
  • amorolfine - antifungal - Loceryl (New drug) 19(1) 24-7
    		•
  • antifungal drugs 19(3) 72-5
    		•
  • terbinafine (PBAC question) 22(6) 135
    		•
  • terbinafine (PBAC question) (letter) 23(4) 72
    		•
    ophthalmic solutions
  • correct use of eye drops 31(1) 16-17
    		•
    ophthalmic surgery
  • flurbiprofen - mydriatic - Ocufen (New drug) 17(1) 6-8
    		•
    ophthalmology
  • verteporfin - macular degeneration - Visudyne (New drug) 23(6) 137-9
    		•
    opioids
  • buprenorphine - Subutex (New drug) 24(3) 71-5
    		•
  • correction 24(5) 129-31
    		•
  • drug treatment for opioid dependence 24(1) 4-6
    		•
  • letter 24(3) 51-5
    		•
  • drug-seeking behaviour 20(3) 68-70
    		•
  • dental implications 20(3) 61-4
    		•
  • hydromorphone - Dilaudid (New drug) 23(4) 84-7
    		•
  • morphine and methadone in cancer (letter) 23(5) 93-6
    		•
  • naltrexone - ReVia (New drug) 22(2) 43-7
    		•
  • letter 22(5) 103-5
    		•
  • neuropathic pain 29(3) 72-5
    		•
  • in palliative care 19(3) 66-8
    		•
  • letter - dosage forms 20(1) 3-4
    		•
  • pethidine 25(1) 12-3
    		•
  • letter 25(4) 79-80
    		•
  • pharmacology 19(3) 63-5
    		•
  • in postoperative pain management 18(4) 88-91
    		•
  • prescription statistics 19(3) 66-8
    		•
  • tramadol - Tramal (New drug) 21(4) 108-11
    		•
    OptiMARK
  • see gadoversetamide 24(3) 71-5
    		•
    oral contraceptives - see contraceptives
    oral mucositis
  • palifermin - Kepivance (New drug) 28(6) 156-8
    		•
    oral rehydration solutions
  • gastroenteritis (letter) 17(1) 4-5
    		•
    Oralmat Drops
  • for oral pain relief in cytotoxic therapy (letter) 19(2) 36-8
    		•
    Oratane
  • see isotretinoin 24(4) 100-2
    		•
    Orelox
  • see cefpodoxime 19(3) 81-3; 17(3) 73
    		•
    Orencia
  • see abatacept 30(6) 163-7
    		•
    Orgalutran
  • see ganirelix 24(6) 155-8
    		•
    Orgaran
  • see danaparoid 17(3) 73
    		•
    orlistat
  • management of obesity 29(2) 43-7
    		•
  • obesity - Xenical (New drug) 23(3) 64-7
    		•
    Orocho
  • see live cholera vaccine 23(4) 84-7
    		•
    Orphan Drug Scheme
  • rifampicin and MRSA infections (letter) 29(1) 3-5
    		•
    orthopaedic surgery
  • low molecular weight heparins 19(4) 104-8
    		•
    Orudis
  • see ketoprofen 19(2) 38-40; 17(4) 87-90
    		•
    oseltamavir
  • influenza - Tamiflu (New drug) 24(2) 43-7
    		•
    osteitis deformans - see Paget's disease of bone
    osteoarthritis - see also arthritis
  • celexocib prescriptions and adverse effects (PBAC question) 24(1) 7-8
    		•
  • correction 24(3) 64
    		•
  • cyclo-oxygenase inhibitors (editorial) 23(2) 26-7
    		•
  • glucosamine (PBAC question) 28(2) 48
    		•
  • lumiracoxib - Prexige (New drug) 29(1) 25-7
    		•
  • meloxicam - osteoarthritis - Mobic (New drug) 25(2) 44-7
    		•
  • non-pharmacological treatment 18(1) 2-4
    		•
  • letter 18(4) 84-6
    		•
  • rofecoxib - Vioxx (New drug) 23(6) 137-9
    		•
  • of the knee - glucosamine 27(3) 61-3
    		•
  • letter 27(5) 109-13
    		•
    osteomyelitis
  • rifampicin (PBAC question) 17(4) 95
    		•
    osteomyelitis diagnosis
  • sulesomab - LeukoScan (New drug) 25(3) 74-5
    		•
    osteonecrosis
  • bisphosphonates and avascular necrosis of the jaw (letter) 27(2) 28-33
    		•
  • bisphosphonates and osteonecrosis of the jaws 30(4) 96-7
    		•
    osteoporosis
  • alendronate - Fosamax (New drug) 19(4) 108-11
    		•
  • bisphosphonate pharmacology 23(6) 130-2
    		•
  • bisphosphonates 23(6) 133-6
    		•
  • bisphosphonates (letter) 24(3) 51-5
    		•
  • bisphosphonates and alendronate (PBAC question) 24(2) 41
    		•
  • bisphosphonates and osteonecrosis of the jaws 30(4) 96-7
    		•
  • calcium supplementation 26(6) 126-7
    		•
  • letter 27(4) 82-3
    		•
  • consensus conference (editorial) 20(4) 82-3
    		•
  • letter 21(2) 31-4
    		•
  • hormone replacement therapy 26(1) 8-10; 23(5) 90-2
    		•
  • raloxifene - Evista (New drug) 22(4) 95-8
    		•
  • risedronate - Actonel (New drug) 24(1) 20-3
    		•
  • strontium ranelate - Protos (New drug) 28(6) 156-8
    		•
  • teriparatide - Forteo (New drug) 27(1) 21-3
    		•
  • letter 27(5) 109-13
    		•
  • thiazide diuretics 24(3) 65-7
    		•
  • thyroxine in subclinical hypothyroidism 22(6) 132-4
    		•
  • tibolone - Livial (New drug) 23(4) 84-7
    		•
    otitis media
  • amoxycillin vs Augmentin - drug advertising (letter) 17(3) 55-6
    		•
  • childhood - management in general practice 17(4) 82-4
    		•
  • childhood - specialist management 17(4) 84-7
    		•
    ovarian cancer
  • hexamethylmelamine - Hexalen (New drug) 17(2) 30-2
    		•
  • paclitaxel - Taxol (New drug) 17(4) 87-90
    		•
  • topotecan - Hycamtin (New drug) 20(4) 101-3
    		•
    overactive bladder
  • darifenacin hydrobromide - Enablex (New drug) 29(5) 138-43
    		•
  • solifenacin succinate - Vesicare - (New drug) 29(5) 138-43
    		•
  • tolterodine - Detrusitol (New drug) 28(2) 49-51
    		•
    overdose
  • activated charcoal 20(1) 14-6
    		•
  • drug screens 24(4) 90-1
    		•
  • paracetamol 23(3) 60-1
    		•
  • psychostimulant poisoning 29(4) 109-11
    		•
  • tricyclic antidepressants (letter) 17(2) 28-9
    		•
    over-the-counter medicines
  • aspirin, alcohol and gastric bleeding 28(1) 18-9
    		•
  • letter 28(4) 84-7
    		•
  • cold remedy precipitating serotonin syndrome 29(3) 71
    		•
  • letter 29(6) 149-50
    		•
  • overdoses of anticholinergic drugs in infantile colic 29(3) 83
    		•
  • over-the-counter medicines - children 24(6) 149-51
    		•
  • letter 25(2) 27-8
    		•
  • regulation of advertising 27(5) 124-7
    		•
  • retail pharmacy promotions (letters) 27(2) 28-33; 26(5) 99-102
    		•
    overweight - see obesity
    ovulation detection
  • fertility testing - abnormal laboratory results 25(2) 38-40
    		•
    ovulation inducers - see fertility drugs
    oxaliplatin
  • colorectal cancer 25(5) 108-10; 25(5) 111-3
    		•
  • colorectal cancer - Eloxatin (New drug) 24(3) 71-5
    		•
  • letter 24(5) 107-9
    		•
    oxazolidinone antibiotics
  • linezolid - Zyvox (New drug) 25(2) 44-7
    		•
    oxcarbazepine
  • epilepsy - Trileptal (New drug) 25(1) 20-3
    		•
  • Trileptal (New formulation) 25(4) 94-9
    		•
    oximetry
  • diagnostic tests 26(6) 132-5
    		•
  • nail polish removal (letter) 27(2) 28-33
    		•
    oxybutynin
  • overactive bladder 29(1) 22-4
    		•
  • urinary incontinence - Ditropan (New drug) 17(4) 87-90
    		•
    oxycodone
  • OxyContin (New formulation) 22(5) 125-7
    		•
  • OxyContin (New strength) 27(1) 21-3
    		•
  • OxyNorm (New formulation) 24(2) 43-7
    		•
  • OxyNorm (New strength) 24(3) 71-5
    		•
    OxyContin
  • see oxycodone 27(1) 21-3; 22(5) 125-7
    		•
    oxygen therapy
  • in chronic obstructive pulmonary disease 24(6) 152-5
    		•
  • domiciliary 19(3) 69-71
    		•
    OxyNorm
  • see oxycodone 24(3) 71-5; 24(2) 43-7
    		•
    Home     Contact Us     Useful Links     Copyright     Privacy     Web Manager